A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?

Article

A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?

Journal of the International Association of Physicians in AIDS Care - 1 Sept 1995

Mascolini M

Abstract excerpt

The debate of monotherapy vs. combination therapy during the July 25th-27th Consensus Symposium on Combined Antiviral Therapy is discussed. Specific topics addressed at the Lisbon conference included whether the protease inhibitor, indinavir, could antagonize the effects of ZDV plus 3TC; synergy claimed with VX-478 and ZDV, ddI, and other reverse transcriptase inhibitors; a proposal that ablative therapy against...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?PMID 11362792Read

Mixing and matching drugs: what makes sense?Semantic proximity Read

3TC approved: now for the tough questions.Semantic proximity Read

Conference highlight.Semantic proximity Read

Nelfinavir is number 4 -- but should it bat cleanup, or lead off?Semantic proximity Read

Should we argue with success?Semantic proximity Read

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read

Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?Semantic proximity Read

Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.Semantic proximity Read